Core Insights - Inspire Medical Systems, Inc. (NYSE: INSP) specializes in innovative medical solutions for sleep apnea and has been a significant player in the medical device industry [1] - RBC Capital downgraded INSP from "Outperform" to "Sector Perform" with the stock priced at $81.33 at the time of the downgrade [1][6] Shareholder Activity - Baillie Gifford & Co. reduced its stake in Inspire Medical by 2.7%, selling 29,538 shares, leaving them with 1,084,350 shares valued at $80.5 million [2] - Texas Permanent School Fund Corp increased its holdings by 42.2%, now owning 40,042 shares valued at $5.2 million, indicating confidence in the company's future [3] - Nordea Investment Management AB acquired a new position valued at approximately $1.6 million, further reflecting investor interest [3] Stock Performance - The current stock price of INSP is $81.33, reflecting a 2.43% increase or $1.93, with fluctuations between $78.17 and $81.76 on the day [4] - Over the past year, the stock reached a high of $203.12 and a low of $70.77, indicating significant volatility [4] - The market capitalization of Inspire Medical stands at approximately $2.41 billion [4] Trading Activity - The trading volume for INSP on the NYSE is 1,084,065 shares, indicating active investor interest despite the recent downgrade [5]